Search & Analyze

Novartis India Ltd.

TradingTrading

www.novartis.in BSE: 500672NSE: NOVARTIND

₹1,996.85BSE7.13%

16 Sep, 4:01 PM

₹1,996.85

₹4.93K Cr

50.43

5.80

13.19%

₹2,185.25

₹1,976.85

₹2,588.00

₹750.00

Customise metrics bar

Price Performance

Peer Comparison

Name
ADANI ENTER ADANIENT	2,924.10	39.65	3,95,842.03	0.04	-890.34	-280.29%	5,953.89	1.30%	24.62
AEGISLOG AEGISLOG	1,381.20	38.22	48,480.12	0.63	394.15	469.75%	1,068.73	27.75%	34.89
CPPLUS CPPLUS	3,555.00	93.15	42,055.80	0.05	140.89	353.03%	1,398.59	91.36%	31.52
PREMIERENE PREMIERENE	899.00	275.09	40,810.24	0.11	28.69	22.30%	176.36	-5.68%	10.13
REDINGTON REDINGTON	387.35	22.23	30,282.03	1.55	321.01	60.34%	20,753.20	62.68%	26.87
HONASA HONASA	471.35	64.96	15,367.15	0.64	84.31	111.30%	696.32	19.31%	19.87
LLOYDSENT LLOYDSENT	66.70	207.51	10,182.10	0.22	2.44	-98.90%	43.11	-56.19%	6.50
Novartis India Ltd. NOVARTIND	1,996.85	50.43	4,930.38	0.00	32.21	16.62%	103.81	18.57%	17.15

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	81.17	92.29	87.10	93.00	83.88	87.55	90.33	85.90	90.55	103.81
Expenses	69.96	68.32	69.14	67.42	59.97	60.31	66.45	63.54	69.93	68.90
	11.21	23.97	17.96	25.58	23.91	27.24	23.88	22.36	20.62	34.91
	13.81%	25.97%	20.62%	27.51%	28.51%	31.11%	26.44%	26.03%	22.77%	33.63%
	10.42	10.41	10.32	10.60	10.63	10.61	9.40	8.75	10.01	8.74
Interest	0.16	0.15	0.14	0.36	0.12	0.10	0.11	0.98	0.07	0.06
	0.14	0.55	0.58	0.53	0.53	0.53	0.52	0.48	0.42	0.42
	21.33	33.68	27.56	35.29	33.89	37.22	32.65	29.65	30.14	43.17
	31.18%	23.57%	25.94%	27.88%	13.54%	25.79%	25.82%	45.73%	16.22%	25.39%
	14.68	25.74	20.41	25.45	29.30	27.62	24.22	16.09	25.25	32.21
	5.95	10.43	8.27	10.31	11.87	11.19	9.81	6.52	10.23	13.05

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2020-21 (Mar)	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	453.73	486.66	413.52	366.84	390.09
	381.35	399.87	378.74	335.07	356.27
EXPENDITURE :
Increase/Decrease in Stock	10.73	-9.12	2.35	9.86	3.75
Raw Material Consumed	135.88	187.26	199.34	189.98	199.07
Power & Fuel Cost	0.53	0.53	0.35	0.18	0.14
Employee Cost	108.51	101.89	35.64	22.96	18.72
Other Manufacturing Expenses	36.52	34.49	15.51	7.54	11.08
General and Administration Expenses	12.95	18.61	17.09	15.37	12.44
Selling and Distribution Expenses	39.77	35.66	27.98	15.87	10.58
Miscellaneous Expenses	10.77	3.80	15.40	8.05	9.07
	355.66	373.12	313.66	269.81	264.85
Operating Profit (Excl OI)	25.69	26.75	65.08	65.26	91.42
	34.19	33.55	58.11	61.68	41.96
	59.88	60.30	123.19	126.94	133.38
Interest	7.68	4.83	1.75	1.49	0.77
PBDT	52.20	55.47	121.44	125.45	132.61
	12.16	9.65	6.06	2.61	2.19
Profit Before Taxation & Exceptional Items	40.04	45.82	115.38	122.84	130.42
Exceptional Income / Expenses		-49.64
	40.04	-3.82	115.38	122.84	130.42
Provision for Tax	19.14	-0.10	12.02	37.65	29.52
	20.90	-3.72	103.36	85.19	100.90
Consolidated Net Profit	20.90	-3.72	103.36	85.19	100.90
Profit Balance B/F	708.04	698.16	677.94	759.72	728.84
Appropriations	728.94	694.44	781.30	844.91	829.74
Equity Dividend %	200.00%	200.00%	950.00%	500.00%	500.00%
	8.47	-1.51	41.88	34.52	40.88
Adjusted EPS	8.47	-1.51	41.88	34.52	40.88

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2020-21 (Mar)	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)
	12.34	12.34	12.34	12.34	12.34
Share Warrants & Outstandings	-2.95	-2.22	-0.04
Total Reserves	701.80	681.58	763.36	732.48	772.62
Reserve excluding Revaluation Reserve	701.80	681.58	763.36	732.48	772.62
	711.19	691.70	775.66	744.82	784.96
Deferred Tax Assets / Liabilities	-30.27	-27.18	-15.80	-15.37	-15.48
Other Long Term Liabilities	51.35	19.60	25.18	5.29	3.41
Long Term Provisions	1,109.57	991.58	998.39	726.33	708.90
Total Non-Current Liabilities	1,130.65	984.00	1,007.77	716.25	696.83
Trade Payables	55.20	72.20	59.67	61.59	51.47
Other Current Liabilities	69.64	45.34	38.03	33.54	24.83
Short Term Borrowings				0.02
Short Term Provisions	232.42	216.93	170.56	304.68	349.82
Total Current Liabilities	357.26	334.47	268.26	399.83	426.12
Total Liabilities	2,199.10	2,010.17	2,051.69	1,860.90	1,907.91
Gross Block	74.81	40.71	38.92	28.36	9.08
Less: Accumulated Depreciation	10.90	17.06	19.67	21.42	4.54
Net Block	63.91	23.65	19.25	6.94	4.54
Long Term Loans & Advances	1,205.11	1,148.65	1,240.75	903.63	870.18
Other Non Current Assets	7.73	11.09	5.59	8.44	3.30
Total Non-Current Assets	1,276.75	1,183.39	1,265.59	919.01	878.02
Inventories	47.95	57.07	54.72	44.86	41.11
Sundry Debtors	38.73	44.56	36.16	41.47	40.14
Cash and Bank	498.88	517.63	555.94	596.08	648.03
Other Current Assets	45.39	15.49	15.95	2.04	2.47
Short Term Loans and Advances	290.49	191.12	123.29	257.44	298.14
Total Current Assets	921.44	825.87	786.06	941.89	1,029.89
Net Current Assets (Including Current Investments)	564.18	491.40	517.80	542.06	603.77
Total Assets	2,199.10	2,010.17	2,051.69	1,860.90	1,907.91
Contingent Liabilities	419.18	422.34	419.25	398.38	378.34
Total Debt	0.00	0.00	0.00	0.02	0.00
	289.36	281.17	314.30	301.79	318.06
Adjusted Book Value	289.36	281.17	314.30	301.79	318.06

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2020-21 (Mar)	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	40.04	-3.82	115.38	122.84	130.42
Adjustment	-4.98	-5.64	-48.92	-56.75	-38.80
Changes In working Capital	-69.08	66.72	-24.00	9.04	-0.76
Cash Flow after changes in Working Capital	-34.02	57.26	42.46	75.13	90.86
Cash Flow from Operating Activities	-69.21	38.67	44.80	113.40	74.57
Cash Flow from Investing Activities	95.16	87.04	-153.25	33.13	-3.31
Cash Flow from Financing Activitie	-36.80	-35.63	-30.48	-120.99	-64.15
Net Cash Inflow / Outflow	-10.85	90.08	-138.93	25.54	7.11
Opening Cash & Cash Equivalents	79.12	68.27	158.35	19.42	44.96
Closing Cash & Cash Equivalent	68.27	158.35	19.42	44.96	52.07

Ratios

Valuation

50.43

5.80

30.74

13.30

39.60

344.28

Profitability

13.19

17.15

5.35

23.44

25.87

Leverage & Liquidity

0.00

2.42

170.38

Returns

0.00

0.21

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	70.68	70.68	70.68	70.68	70.68	70.68	70.68	70.68	70.68
	0.71	0.71	0.71	0.71	0.71	0.71	0.82	0.69	1.51
	28.61	28.61	28.61	28.61	28.61	28.61	28.51	28.63	27.81
	29.32	29.32	29.32	29.32	29.32	29.32	29.32	29.32	29.32
No. of Shareholders	39,265	39,596	38,926	39,133	39,040	39,353	39,468	38,116	36,502

Corporate Actions

Showing: All

Date	Type	Details
2026-09-03	AGM
2026-07-07	Board Meeting	Quarterly Results
2026-04-01	Board Meeting	Audited Results

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)
2026-07-30	NOVARTIS AG	Off Market	Sell	17,450,680

Sector Overview

TradingTrading

Novartis India Ltd. operates in the Trading sector under the Trading industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

7 members across the board and senior leadership

Chandni Maru

Company Secretary & Compliance Officer

—

Ashok Bhatia

Additional Director

—

Kshitij Sheth

Additional Director

—

Ramesh Ramadurai

Additional Director

—

Shashank Sinha

Additional Director

—

Suchita Sharma

Additional Director

—

Jagriti Gupta

Additional Director

—

NOVARTIND Latest News

News

2 of 2 articles

COMPANY15 Jun 2026 · 15:59

Novartis India launches precision radiotherapy ‘Pluvicto’ for prostate cancer

Pluvicto is the country's first regulatory authority-approved radioligand therapy for PSMA -positive prostate cancer

EQUITY12 May 2026 · 14:06

Novartis reports Profit after tax of Rs 252.50 Mln, in the March 2026 quarter

NOVARTIND

₹1,996.85

-7.13%